DR-Positive T Cells in Autism: Association with Decreased Plasma Levels of the Complement C4B Protein
The DOI matches its Crossref record.
Abstract
Autism is a developmental disorder characterized by severe communication, social and behavioral abnormalities. Over the past several years a fair amount of evidence has accumulated suggesting that some cases of autism may be associated with immune abnormalities and with products of the HLA complex including the C4B gene located in the class III region of HLA. This study sought additional evidence for an association of autoimmune processes with autism by investigating the presence of activated T cells in 26 autistic subjects. Fourteen of the autistic subjects had DR+ T cells, an indicator of activated T cells, but none of the autistic subjects had T cells expressing the interleukin-2 receptor, another indicator of T cell activation. Similar findings of incomplete or partial T cell activation have been reported in autoimmune disorders and in a recent study of autism. In the current investigation, the DR+ T cells were not found to be associated with age of the autistic patients but were inversely correlated with a decreased plasma level of the C4B protein. In conclusion, this study provides additional evidence for the involvement of an autoimmune mechanism in autism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“circulating levels of CD4+ T cell populations are low, biased towards an anti-inflammatory (TH2) profile and exhibit a dysfunctional response to stimulation in individuals with ASD126–130.”
From Immune mediators in the brain and peripheral tissues in autism spectrum disorder (2015) · cites this paper as [129]
Citations
Cites
Still being checked.
Cited by
Infant Intersubjectivity: Research, Theory, and Clinical Applications
Trevarthen, C., & Aitken, K. J. (2001) · Journal of Child Psychology and Psychiatry · doi:10.1017/s0021963001006552 · Cited by 1,610
Immune mediators in the brain and peripheral tissues in autism spectrum disorder
Estes, M. L., & McAllister, A. K. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3978 · Cited by 514
Modeling an autism risk factor in mice leads to permanent immune dysregulation
Hsiao, E. Y., McBride, S. W., Chow, J., Mazmanian, S. K., & Patterson, P. H. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202556109 · Cited by 340
“Increases in activated DR T cells are observed in human autism (29, 30).”
BackgroundIntersubjectivité chez le nourrisson : recherche, théorie et application clinique
Trevarthen, C., & Aitken, K. J. (2003) · Devenir · doi:10.3917/dev.034.0309 · Cited by 326
Activation of the Inflammatory Response System in Autism
Croonenberghs, J., Bosmans, E., Deboutte, D., Kenis, G., & Maes, M. (2002) · Neuropsychobiology · doi:10.1159/000048665 · Cited by 322
Altered T cell responses in children with autism
Ashwood, P., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., Pessah, I. N., & Van de Water, J. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.09.002 · Cited by 281
“…such as human leukocyte antigen (HLA)DRB1*04, interleukin (IL)-4 receptor, and complement C4B null allele (Lee et al., 2006; Torres et al., 2006; Warren et al., 1992, 1995), as well as a number of other immune-related genes including macrophage migration inhibitory factor (MIF) (Grigorenko et…”
BackgroundEvidence of Toxicity, Oxidative Stress, and Neuronal Insult in Autism
Kern, J. K., & Jones, A. M. (2006) · Journal of Toxicology and Environmental Health, Part B · doi:10.1080/10937400600882079 · Cited by 265
Connolly, A. M., Chez, M., Streif, E. M., Keeling, R. M., Golumbek, P. T., Kwon, J. M., Riviello, J. J., Robinson, R. G., Neuman, R. J., & Deuel, R. M. K. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.07.004 · Cited by 263
Innate immunity at the crossroads of healthy brain maturation and neurodevelopmental disorders
Zengeler, K. E., & Lukens, J. R. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-00487-7 · Cited by 246
Etiology of infantile autism: a review of recent advances in genetic and neurobiological research.
Trottier, G., Srivastava, L. K., & Walker, C. D. (1999) · PubMed Central · Cited by 247
Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders
Connolly, A. M., Chez, M. G., Pestronk, A., Arnold, S. T., Mehta, S., & Deuel, R. K. (1999) · The Journal of Pediatrics · doi:10.1016/s0022-3476(99)70248-9 · Cited by 236
Circulating autoantibodies to neuronal and glial filament proteins in autism
Singh, V. K., Warren, R., Averett, R., & Ghaziuddin, M. (1997) · Pediatric Neurology · doi:10.1016/s0887-8994(97)00045-3 · Cited by 234
Self-citationPlasma increase of interleukin-12 and interferon-gamma. Pathological significance in autism
Singh, V. K. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(96)00014-8 · Cited by 199
Corbett, B. A., Kantor, A. B., Schulman, H., Walker, W. L., Lit, L., Ashwood, P., Rocke, D. M., & Sharp, F. R. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001943 · Cited by 197
Colonic CD8 and γδ T-cell infiltration with epithelial damage in children with autism
Furlano, R. I., Anthony, A., Day, R., Brown, A., McGarvey, L., Thomson, M. A., Davies, S. E., Berelowitz, M., Forbes, A., Wakefield, A. J., et al. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.111323 · Cited by 195
Tye, C., Runicles, A. K., Whitehouse, A. J. O., & Alvares, G. A. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00751 · Cited by 177
High nitric oxide production in autistic disorder: a possible role for interferon-γ
Sweeten, T. L., Posey, D. J., Shankar, S., & McDougle, C. J. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.09.001 · Cited by 172
Neurotoxic effects of postnatal thimerosal are mouse strain dependent
Hornig, M., Chian, D., & Lipkin, W. I. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001529 · Cited by 161
Immune Dysfunction in Autism: A Pathway to Treatment
Careaga, M., Van de Water, J., & Ashwood, P. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.05.003 · Cited by 159
Brain‐Specific Autoantibodies in the Plasma of Subjects with Autistic Spectrum Disorder
CABANLIT, M., WILLS, S., GOINES, P., ASHWOOD, P., & VAN DE WATER, J. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1381.010 · Cited by 157
Halsey, N. A., Hyman, S. L., & Panel, T. C. W. (2001) · Pediatrics · doi:10.1542/peds.107.5.e84 · Cited by 155
In Search of Cellular Immunophenotypes in the Blood of Children with Autism
Ashwood, P., Corbett, B. A., Kantor, A., Schulman, H., Van de Water, J., & Amaral, D. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019299 · Cited by 140
Moaaz, M., Youssry, S., Elfatatry, A., & Abdel-Rahman, M. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.577071 · Cited by 133
Torres, A., Maciulis, A., Stubbs, E. G., Cutler, A., & Odell, D. (2002) · Human Immunology · doi:10.1016/s0198-8859(02)00374-9 · Cited by 134
Self-citationStrong association of the third hypervariable region of HLA-DRβ1 with autism
Warren, R. P., Odell, J. D., Warren, W. L., Burger, R. A., Maciulis, A., Daniels, W. W., & Torres, A. R. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(96)00052-5 · Cited by 130
“, activated T cells (Plioplys et al., 1994b; Warren et al., 1995a) and depressed natural killer cell function (Warren et al., 1987).”
BackgroundSelf-citationIncreased serum albumin, γ globulin, immunoglobulin IgG, and IgG2 and IgG4 in autism
CROONENBERGHS, J., WAUTERS, A., DEVREESE, K., VERKERK, R., SCHARPE, S., BOSMANS, E., EGYED, B., DEBOUTTE, D., & MAES, M. (2002) · Psychological Medicine · doi:10.1017/s0033291702006037 · Cited by 128
Immune Abnormalities in Autism Spectrum Disorder—Could They Hold Promise for Causative Treatment?
Gładysz, D., Krzywdzińska, A., & Hozyasz, K. K. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0822-x · Cited by 127
Enstrom, A. M., de Water, J. V., & Ashwood, P. (2009) · PubMed · Cited by 128
Purkinje cell vulnerability and autism: a possible etiological connection
Kern, J. K. (2003) · Brain and Development · doi:10.1016/s0387-7604(03)00056-1 · Cited by 123
Macrophage migration inhibitory factor and autism spectrum disorders
Grigorenko, E. L., Han, S. S., Yrigollen, C. M., Leng, L., Mizue, Y., Anderson, G. M., Mulder, E. J., de Bildt, A., Minderaa, R. B., Volkmar, F. R., et al. (2008) · PEDIATRICS · doi:10.1542/peds.2007-3604 · Cited by 118
Confirmation of the association of the C4B null allelle in autism
Odell, D., Maciulis, A., Cutler, A., Warren, L., McMahon, W. M., Coon, H., Stubbs, G., Henley, K., & Torres, A. (2005) · Human Immunology · doi:10.1016/j.humimm.2004.11.002 · Cited by 110
Self-citationIncreased IgG4 levels in children with autism disorder
Enstrom, A., Krakowiak, P., Onore, C., Pessah, I. N., Hertz-Picciotto, I., Hansen, R. L., Van de Water, J. A., & Ashwood, P. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.12.005 · Cited by 101
“Multiple genetic studies of children and adults with autism have indicated various candidate genes, many of them related to immune system function, including C4 null allele and MHC haplotypes B44-SC30-DR4, HLA-DR b1, DR4, and DR13 (Daniels et al., 1995; Ferrante et al., 2003; Lee et al., 2006; Torres et al., 2006; War…”
Complement and microglia dependent synapse elimination in brain development
Soteros, B. M., & Sia, G.-M. (2021) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.1545 · Cited by 101
Hornig, M., & Lipkin, W. I. (2001) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.1028 · Cited by 89
Effectiveness of N,N-Dimethylglycine in Autism and Pervasive Developmental Disorder
Kern, J. K., Miller, V. S., Cauller, L., Kendall, R., Mehta, J., & Dodd, M. (2001) · Journal of Child Neurology · doi:10.1177/088307380101600303 · Cited by 86
Torrente, F., Anthony, A., Heuschkel, R. B., Thomson, M. A., Ashwood, P., & Murch, F. (2004) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04142.x · Cited by 76
Brief Report: Immune Factors in Autism: A Critical Review
Krause, I., He, X.-S., Gershwin, M. E., & Shoenfeld, Y. (2002) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1016391121003 · Cited by 80
Immunological Treatments for Autism
Gupta, S. (2000) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1005568027292 · Cited by 80
Hyperserotoninemia and Altered Immunity in Autism
Burgess, N. K., Sweeten, T. L., McMahon, W. M., & Fujinami, R. S. (2006) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-006-0100-7 · Cited by 69
Theoretical aspects of autism: biomarkers—a review
Ratajczak, H. V. (2011) · Journal of Immunotoxicology · doi:10.3109/1547691x.2010.538749 · Cited by 57
The Neuroimmunological Basis of Behavior and Mental Disorders
Siegel, A., & Zalcman, S. S. (2008) · Springer eBooks · doi:10.1007/978-0-387-84851-8 · Cited by 52
Westacott, L. J., & Wilkinson, L. S. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.840266 · Cited by 49
Complement C4B protein in schizophrenia
Mayilyan, K. R., Dodds, A. W., Boyajyan, A. S., Soghoyan, A. F., & Sim, R. B. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970701227803 · Cited by 49
The association of MHC genes with autism
Torres, A. (2001) · Frontiers in Bioscience · doi:10.2741/torres · Cited by 48
Trajkovski, V., Ajdinski, L., & Spiroski, M. (2018) · doi:10.31235/osf.io/vrt3b · Cited by 42
Edelson, S. B., & Cantor, D. S. (1998) · Toxicology and Industrial Health · doi:10.1177/074823379801400406 · Cited by 46
Basheer, S., Venkataswamy, M. M., Christopher, R., van Amelsvoort, T., Srinath, S., Girimaji, S. C., & Ravi, V. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.05.002 · Cited by 44
Intra-monocyte pathogens delineate autism subgroups
Binstock, T. (2001) · Medical Hypotheses · doi:10.1054/mehy.2000.1247 · Cited by 40
Bradstreet, J. J., Smith, S. A., Granpeesheh, D., El-Dahr, J. M., & Rossignol, D. A. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.10.015 · Cited by 40
Autism Spectrum Disorders: From Immunity to Behavior
Careaga, M., & Ashwood, P. (2012) · Methods in Molecular Biology · doi:10.1007/978-1-62703-071-7_12 · Cited by 38
Involvement of C4 allotypes in the pathogenesis of human diseases
Samano, E. S. T., Ribeiro, L. D. M., Gorescu, R. G., Rocha, K. C., & Grumach, A. S. (2004) · Revista do Hospital das Clínicas · doi:10.1590/s0041-87812004000300009 · Cited by 38
Brief report: Alternative approaches to the development of effective treatments for autism
Rimland, B., & Baker, S. M. (1996) · Journal of Autism and Developmental Disorders · doi:10.1007/bf02172019 · Cited by 34
Shaw, W. M., Kassen, E., & Chaves, E. (2000) · Cited by 32
Heuer, L. S., Rose, M., Ashwood, P., & Van de Water, J. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.07.001 · Cited by 28
Measurement in Saliva From Neurotypical Adults of Biomarkers Pertinent to Autism Spectrum Disorders
Ratajczak, H. V., & Sothern, R. B. (2015) · Future Science OA · doi:10.4155/fso.15.70 · Cited by 27
Childhood Autism: A Circuit Syndrome?
Lee, D. A., Lopez-Alberola, R., & Bhattacharjee, M. B. (2003) · The Neurologist · doi:10.1097/01.nrl.0000051441.03160.e0 · Cited by 26
Anti-metallothionein IgG and levels of metallothionein in autistic families
Russo, A. (2008) · Swiss Medical Weekly · doi:10.4414/smw.2008.12014 · Cited by 25
Mycobacterium paratuberculosis and autism: Is this a trigger?
Dow, C. T. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.08.024 · Cited by 24
Prevalence of Resistence to Activated Protein C (Apc-Resistance) in Blood Donors in Kosovo
Mekaj, Y., Zhubi, B., Hoxha, H., Belegu, R., Miftari, E., & Belegu, M. (2009) · Biomolecules and Biomedicine · doi:10.17305/bjbms.2009.2789 · Cited by 23
Decreased Expression of CD95 (FAS/APO-1) on CD4+ T-lymphocytes from Participants with Autism
Engström, H. A., Ohlson, S., Stubbs, E. G., Maciulis, A., Caldwell, V. D., Odell, J. D., & Torres, A. R. (2003) · Journal of Developmental and Physical Disabilities · doi:10.1023/a:1022827417414 · Cited by 23
The effectiveness of secretin in the management of autism
Kern, J. K., Espinoza, E., & Trivedi, M. H. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.2.379 · Cited by 20
Ahmad, S. F., Nadeem, A., Ansari, M. A., Bakheet, S. A., AL-Ayadhi, L. Y., & Attia, S. M. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.04.011 · Cited by 19
Immunotherapy for brain diseases and mental illnesses
Singh, V. K. (1997) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8861-5_5 · Cited by 19
Immunizations, immunology, and autism
Chez, M. G., Chin, K., & Hung, P. C. (2004) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2004.07.005 · Cited by 19
Santaella, M. L., Varela, Y., Línares, N. L., & Disdier, O. M. (2008) · PubMed · Cited by 17
Tye, C., Runicles, A. K., Whitehouse, A., & Alvares, G. A. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00438 · Cited by 17
Long, J., Dang, H., Su, W., Moneruzzaman, M., & Zhang, H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1370276 · Cited by 16
Endothelial antibody levels in the sera of children with autism spectrum disorders
Bashir, S., & AL-Ayadhi, L. Y. (2015) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2015.01.008 · Cited by 16
Pathogenesis of Autism: A Patchwork of Genetic Causes
Grigorenko, E. L. (2009) · Future Neurology · doi:10.2217/fnl.09.29 · Cited by 17
AL-Ayadhi, L. Y. (2011) · The Open Conference Proceedings Journal · doi:10.2174/2210289201102010036 · Cited by 15
Family Analysis of Immunoglobulin Classes and Subclasses in Children with Autistic Disorder
Spiroski, M. Z., Trajkovski, V., Трајков, Д., Петличковски, А., Ефинска-Младеновска, О., Hristomanova, S., Djulejic, E., Paneva, M., & Božikov, J. (2009) · Biomolecules and Biomedicine · doi:10.17305/bjbms.2009.2780 · Cited by 15
Neuropsychiatric disorders: An immunological perspective
Aw, E., Zhang, Y., Yalçın, E., Herrmann, U., & Carroll, M. C. (2021) · Advances in immunology · doi:10.1016/bs.ai.2021.09.002 · Cited by 13
Anti-metallothionein IgG and levels of metallothionein in autistic children with GI disease
Russo, A. J. (2009) · Drug Healthcare and Patient Safety · doi:10.2147/dhps.s4342 · Cited by 12
Edelson, S. B., & Cantor, D. S. (1998) · Toxicology and Industrial Health · doi:10.1177/074823379801400603 · Cited by 11
DNA typing of HLA-A, -C, -B, AND -DRB1 in the children with autism in the Republic of Macedonia
Trajkovski, V., & Spiroski, M. Z. (2015) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2015_003 · Cited by 10
Liêm, N. T., Nguyen, P. M., Nguyen, H.-P., Bui, H. T., Dao, L. T. M., Pham, M. V., Hoang, C. K., Nguyen, P. T., Nguyễn, T. T. P., Nguyen, A. T. P., et al. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04404-4 · Cited by 9
An Immunologic Theory for the Development of Some Cases of Autism
Warren, R. P. (1998) · CNS Spectrums · doi:10.1017/s109285290000571x · Cited by 10
Self-citationAutoimmunity and Brain Dysfunction
Hoffman, S. A., & Šakić, B. (2008) · Springer eBooks · doi:10.1007/978-0-387-84851-8_17 · Cited by 8
Autism spectrum disorders: etiology, treatment. models and experimental studies
Lavrov, N. V., & Shabanov, P. D. (2018) · Reviews on Clinical Pharmacology and Drug Therapy · doi:10.17816/rcf16121-27 · Cited by 7
Progress in the Neurobiology of Autism
Rapin, I. (1998) · CNS Spectrums · doi:10.1017/s1092852900005691 · Cited by 5
Understanding on Neuroimmunology in Autism Spectrum Disorder
Depino, A. M., & Robinson‐Agramonte, M. D. L. Á. (2015) · Springer eBooks · doi:10.1007/978-3-319-16321-5_9 · Cited by 5
Pervasive Developmental Disorders
Oswald, D. P. (1998) · Elsevier eBooks · doi:10.1016/b0080-4270(73)00171-1 · Cited by 5
Pathophysiology of autism: current opinions
Croonenberghs, J., Deboutte, D., & Maes, M. H. J. (2002) · Acta Neuropsychiatrica · doi:10.1034/j.1601-5215.2002.140209.x · Cited by 5
Shaw, W., Baptist, J., Allergy Link, P. A., & Geenens, D. (2010) · North American Journal of Medicine and Science · doi:10.7156/v3i1p001 · Cited by 4
Immune Dysfunction in Autism Spectrum Disorders
Careaga, M., de Water, J. V., & Ashwood, P. (2012) · Molecular and integrative toxicology · doi:10.1007/978-1-61779-812-2_10 · Cited by 3
Immune Abnormalities and Autism Spectrum Disorders
Akintude, M. E., Heuer, L. S., & de Water, J. V. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-391924-3.00016-8 · Cited by 3
Immunological and Immunogenetic Changes in Children with Autistic Disorder in Republic of Macedonia
Spiroski, M. Z. (2015) · South East European Journal of Immunology · doi:10.3889/seejim.2015.20003 · Cited by 2
Alves, C., Souza, T., Toralles, M. B. P., & Oliveira, I. (2006) · Revista de Psiquiatria do Rio Grande do Sul · doi:10.1590/s0101-81082006000200010 · Cited by 2
Knutsen, A. P., & Fenton, G. A. (1998) · Pediatric Asthma Allergy & Immunology · doi:10.1089/pai.1998.12.213 · Cited by 2
Prenatal β2-Adrenergic Receptor Signaling and Autism:
Connors, S. L. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-489-0_7 · Cited by 2
Autism, Gastrointestinal Disturbance, and Immune Dysfunction: What Is the Link?
Ashwood, P., Enstrom, A. M., & de Water, J. V. (2009) · CRC Press eBooks · doi:10.1201/9781420068870-c14 · Cited by 1
Edelson, S. B., & Cantor, D. S. (1999) · Journal of Advancement in Medicine · doi:10.1023/b:jame.0000008713.66347.dc
Gupta, V. B. (2004) · CRC Press eBooks · doi:10.1201/9780203026229-9
Gupta, V. B. (2004) · CRC Press eBooks · doi:10.1201/9780203026229.ch3
Fatores imunobiológicos e perfil de desenvolvimento no autismo infantil
Tostes, M. H. F. D. S. (2012) · Americanae (AECID Library)
Long, J., Dang, H., Su, W., Moneruzzaman, M., & Zhang, H. (2024) · doi:10.3389/fimmu.2024.1370276.s001
Burger (1998) · doi:10.1002/(sici)1098-2779(1998)4:2<137::aid-mrdd11>3.0.co;2-w
Self-citation
Metadata
- Authors
- Warren, R. P., Yonk, J., Burger, R. W., Odell, D., & Warren, W. L.
- Affiliations
- Utah State University (US)
- Venue
- Neuropsychobiology
- Publisher
- S. Karger AG
- Published
- 2008-02-26
- Volume
- 31
- Issue
- 2
- Pages
- 53-57
- ISSN
- 0302-282X (ISSN-L)
- 1423-0224
- OpenAlex
- W2078790950
- Cited by
- 93
- References
- 0
- Citations by year
- 2025: 1 · 2024: 1 · 2022: 1 · 2021: 3 · 2019: 2 · 2018: 4 · 2015: 6 · 2012: 5
- FWCI
- 3.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- karger.com/pages/terms-and-conditions (vor)
- karger.com/pages/terms-and-conditions (tdm)
- Locations
- Neuropsychobiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Willard L. Eccles Charitable Foundation
- National Institutes of Health (5r01mh042119-10)
- National Institute of Mental Health (MH-42119)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Keywords
- autism spectrum disorder, T cell activation, HLA-DR, complement C4B, interleukin-2 receptor, autoimmune hypothesis, immune abnormalities, HLA class III
- MeSH terms
- Adolescent, Autistic Disorder, Autoimmune Diseases, Child, Child, Preschool, Female, Humans, Lymphocyte Activation, Male, Receptors, Interleukin-2, Complement C4a, Complement C4b, T-Lymphocyte Subsets
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.